Back to Search
Start Over
HER2 amplification as a potential mechanism of acquired resistance to afatinib in an advanced non-small-cell lung cancer patient.
- Source :
-
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2021 Jan; Vol. 151, pp. 106-107. Date of Electronic Publication: 2020 Nov 13. - Publication Year :
- 2021
- Subjects :
- Afatinib pharmacology
Afatinib therapeutic use
Humans
Mutation drug effects
Protein Kinase Inhibitors pharmacology
Protein Kinase Inhibitors therapeutic use
Quinazolines therapeutic use
Carcinoma, Non-Small-Cell Lung drug therapy
Carcinoma, Non-Small-Cell Lung genetics
Drug Resistance, Neoplasm drug effects
Drug Resistance, Neoplasm genetics
ErbB Receptors genetics
Lung Neoplasms drug therapy
Lung Neoplasms genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1872-8332
- Volume :
- 151
- Database :
- MEDLINE
- Journal :
- Lung cancer (Amsterdam, Netherlands)
- Publication Type :
- Editorial & Opinion
- Accession number :
- 33309100
- Full Text :
- https://doi.org/10.1016/j.lungcan.2020.11.004